Case Study: Global Athletic Retailer Scales its B2B Resale Program Without Sacrificing Channel ControlJune 1, 2026
AbCellera gains on antibody collaboration with Biogen (NASDAQ:ABCL) Markets March 11, 2024 Love Worker AbCellera Biologics (NASDAQ:ABCL) is up ~3% in Monday buying and selling after saying a collaboration with Biogen (NASDAQ:BIIB)…
